CAN WE IMPROVE GRAFT ACCEPTANCE BY SWITCHING TO VASODILATING BETA BLOCKERS INSTEAD OF NON-VASODILATING?
Facta Universitatis, Series: Medicine and Biology · 30.04.2026 · 027
DOI: 10.22190/fumb250111009k ↗Kurz gefasst
Fachartikel in der Zeitschrift Facta Universitatis, Series: Medicine and Biology, online erschienen am 30.04.2026. Verfasst von Goran Koraćević und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Beta blockers (BBs) are very important medications with numerous indications. They have been considered highly useful in the treatment of arterial hypertension with comorbidities such as heart failure, coronary artery disease, and arrhythmias. The focus of this review is to analyze whether a BB already prescribed to a patient is the right choice, given that BBs differ significantly – for example in their vasodilatory versus vasoconstrictive properties. Searches were performed on 11/11/2024 with the following results. In PubMed, using the search terms "graft acceptance" and "beta adrenergic blocker" (or "graft acceptance" and "beta blocker") no articles were found. In SCOPUS for the combined search terms "graft acceptance" and "beta adrenergic blocker" (or "graft acceptance" and "beta blocker") also yielded no items . In the web based search engine Google Scholar two items were retrieved, but neither was directly related to the topic. The review highlights several important factors influencing graft acceptance, including infection and host- versus- graft reaction, and tissue perfusion. Differences among BBs also affect peripheral vascular resistance and flow; therefore, they may influence tissue perfusion including graft perfusion. This could have consequences for graft acceptance. It is worth investigating whether vasodilatory BBs and/or highly β1-AR selective BBs provide bet-ter protection in graft preservation for patients already receiving BB therapy. The pragmatic outcome of such an investigation may enable clinicians to eventually switch to specific BBs when preparing for elective operations involving tissue graft implantation.
Zitieren
APA
Koraćević, G., Pavlović, D., Mićić, S., Zdravković, M., Đorđević, M., Zdravković, M., Lović, D., Đorđević, D., & Koraćević, M. (2026). CAN WE IMPROVE GRAFT ACCEPTANCE BY SWITCHING TO VASODILATING BETA BLOCKERS INSTEAD OF NON-VASODILATING?. Facta Universitatis, Series: Medicine and Biology, 027. https://doi.org/10.22190/fumb250111009k
Vancouver
Koraćević G, Pavlović D, Mićić S, Zdravković M, Đorđević M, Zdravković M, et al. CAN WE IMPROVE GRAFT ACCEPTANCE BY SWITCHING TO VASODILATING BETA BLOCKERS INSTEAD OF NON-VASODILATING?. Facta Universitatis, Series: Medicine and Biology. 2026:027. doi:10.22190/fumb250111009k
BibTeX
@article{Koraevi2026,
author = {Koraćević, Goran and Pavlović, Dimitrije and Mićić, Slađana and Zdravković, Marija and Đorđević, Milan and Zdravković, Miloš and Lović, Dragan and Đorđević, Dragan and Koraćević, Maja},
title = {CAN WE IMPROVE GRAFT ACCEPTANCE BY SWITCHING TO VASODILATING BETA BLOCKERS INSTEAD OF NON-VASODILATING?},
journal = {Facta Universitatis, Series: Medicine and Biology},
year = {2026},
pages = {027},
doi = {10.22190/fumb250111009k}
}
EUVIMED